Carrie Arnold is a Virginia-based freelance science journalist who covers many aspects of the living world. She’s a contributing editor at NOVA Next, and has also written for Mosaic, National Geographic, Aeon, Nautilus, Scientific American and Women’s Health. She is also the author of “Decoding Anorexia: How Breakthroughs in Science Offer Hope for Eating Disorders.”
Carrie Arnold
From this contributor
Weighing up autism’s obesity crisis
Autism’s underlying biology, associated behaviors and treatments can all put people on the spectrum at serious risk for obesity.
Rare form of autism shows unique pattern of regression
More than 40 percent of children with Phelan-McDermid syndrome lose skills they once had, beginning, on average, at age 6.
Rare form of autism shows unique pattern of regression
By
Carrie Arnold
24 May 2017 | 3 min read
The innovators: How families launch their own autism studies
Some parents are starting ‘N-of-1’ studies for autism, but their efforts don’t always get taken seriously.
The innovators: How families launch their own autism studies
By
Carrie Arnold
28 September 2016 | 20 min read
The invisible link between autism and anorexia
Autism and anorexia may seem to have nothing in common, but below the surface, the two conditions are startlingly similar—and sometimes affect the same person.
The invisible link between autism and anorexia
By
Carrie Arnold
17 February 2016 | 18 min read
Explore more from The Transmitter
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
By
Katie Moisse
15 December 2025 | 7 min read
How basic neuroscience has paved the path to new drugs
A growing list of medications—such as zuranolone for postpartum depression, suzetrigine for pain, and the gepants class of migraine medicines—exist because of insights from basic research.
How basic neuroscience has paved the path to new drugs
A growing list of medications—such as zuranolone for postpartum depression, suzetrigine for pain, and the gepants class of migraine medicines—exist because of insights from basic research.
By
Alex Kwan
15 December 2025 | 6 min read
Dispute erupts over universal cortical brain-wave claim
The debate highlights opposing views on how the cortex transmits information.
Dispute erupts over universal cortical brain-wave claim
The debate highlights opposing views on how the cortex transmits information.
By
Claudia López Lloreda
12 December 2025 | 5 min read